Vision: Eliminate Hearing Loss as a Chronic Condition
Mission: Develop technologies across the disciplines of therapeutics, diagnostics, and imaging.
The RHI vision is to “Eliminate Hearing Loss as a Chronic Condition”. To achieve our vision, we will seek to develop an array of technologies across the disciplines of therapeutics, diagnostics and imaging.
INITIAL PRODUCT PORTFOLIO
The following initial assets will be developed simultaneous with capitalization. Our initial product will be the RHI100 gene therapy product:
- Gene Therapy Product (RHI100) – product will target a specific genetic mutation known to cause hearing loss
- Genetic Testing Product (RHIDx) – companion diagnostic and screening tool- a single gene diagnostic testing product to confirm genetic mutation of interest
- BioMarker Product (RHI HearID) – a biomarker discovery program to identify predictive biomarkers associated with hearing loss.
Imaging Product (RHI InView) – product to assess human inner ear function